Jordi Heijman nominated for the New Scientist Science Talent 2016

Jordi Heijman (FHML) is one of the twenty-five nominees for the New Scientist 2016 Science Talent (Wetenschapstalent) award. Heijman studies the mechanisms that cause cardiac arrhythmias. This knowledge can be used to more quickly determine which people have an increased risk for cardiac arrhythmias and can help researchers develop better treatment methods.

In his research, Heijman uses so-called 'patch clamp' experiments to measure the electrical properties of heart muscle cells. He is also developing computer models that can analyse these data. This leads to the creation of 'virtual heart cells', which can foster our understanding of complex interactions and help us make accurate predictions about the effects of certain medications, for example.

Eighteen universities in Belgium and the Netherlands nominated young and talented candidates in recent months. New Scientist selected twenty-five candidates based on these nominees. The winner of Science Talent 2016 will be determined by an online public vote and a jury vote and will receive a cash prize of 2,500 euros.

The winner will be announced on 22 September 2016. During the ceremony, the five highest-scoring nominees will present their research. Iris Sommer, Erik Scherder and Alexander Sack will also discuss the latest developments in the field of brain research.

The New Scientist Science Talent award was established last year to give young researchers the opportunity to present their research to a broad audience.

Also read

  • Concentration problems. Troubles with planning. Quickly getting distracted. These are all familiar symptoms of ADHD. More and more UM students report ADHD problems to Disability Support. In what ways is ADHD getting in the way of studying? And how can you reduce ADHD symptoms during your studies? We...

  • SBE took first place in the Rotterdam School of Management Star Case Competition (RSMCC). The competition welcomed 16 top-level international business teams of four students, who were tasked with tackling two real-life business cases.

  • Alisa moved from Moscow to the Netherlands at 17 years old to become a first-year Regenerative Medicine and Technology (RMT) bachelor’s student. Turns out Alisa’s adventurous spirit pushes her to brand-new things, such as the RMT bachelor’s programme and her hobby Tribal Fusion dancing.